Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Billionaires Are Crazy About These 10 Stocks

Page 1 of 3

You may think that imitating the stock picks of billionaires will make you rich too. You need a reality check. Billionaires start investing differently after they become billionaires. They put most of their money on large-cap stocks because they have too much money to invest it all into small-caps. However, almost all hedge fund managers, including billionaire hedge fund managers, can’t beat the market by a large enough margin by investing in large-cap stocks. That’s one of the reasons why hedge fund investors have been under-performing the market in recent years.

Hedge Fund Managers

Our research has shown that the 30 most popular stocks among hedge funds outperformed the market by nearly 2 percentage points between 1999 and 2009. Yes, only 2 percentage points. This isn’t enough to justify the high hedge fund fees. On the other hand, investors would have outperformed Vanguard’s index funds by an average of 2 percentage points a year if they had imitated these picks in their personal portfolios. Our research also has shown that hedge funds’ small-cap picks outperformed the market by double digit rates annually between 1999 and 2009 (read the details here). So, overall it is a good idea to pay attention to what hedge funds and billionaires are buying and selling, especially in the small-cap portion of your portfolio.

We recently published the list of the 10 most popular stocks among hedge funds at the close of 2014. Most of those stocks are also very popular among billionaires. This list covers the equity positions of 59 billionaires. We excluded positions that are smaller than $10 million. We ranked each stock by the number of billionaires with bullish positions. As you’ll notice in the forthcoming list, it appears billionaires love merger plays; and credit cards.

1. Allergan, Inc. (NYSE:AGN) is the most popular stock among billionaires. Nearly a third of the billionaires had a position in Allergan at the end of 2014. Billionaires had more than $10 billion invested in the stock, while hedge funds as a group own more than 30% of the stock’s outstanding shares. Bill Ackman, John Paulson, James Dinan and George Soros were among these billionaires. Actavis is in the process of acquiring Allergan. Most billionaires prefer investing in merger arbitrage related stocks; they can get much higher returns than investing in Treasury bonds.

2. Apple Inc. (NASDAQ:AAPLis the second most popular stock among billionaires. 19 billionaires had more than $10 billion invested in Apple, but this corresponds to less than 2% of Apple’s market value, showing that Apple may be too rich even for their blood. Carl Icahn is probably the most well-known billionaire investor in Apple, and an outspoken bull on the tech giant’s potential. Others include Ken Fisher, David Einhorn, and Rob Citrone.

3. Actavis Plc (NYSE:ACT) is third on our list, with 18 of the 59 billionaires owning a stake in the pharmaceutical company, whose deal to buy the number one company on the list, Allergan, was unanimously approved by shareholders of both companies towards the tail end of last year. Despite only one less billionaire being invested in Actavis than the top two, there is a steep drop off in the amount of equity allocated to it, as the billionaires had just $6.20 billion invested. Andreas Halvorsen, Dan Loeb, and Daniel S. Och are a few of the billionaire investors in Actavis.

Page 1 of 3

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!